About this item:

877 Views | 0 Downloads

Author Notes:

Correspondence: Luke P. Brewster, MD, PhD, RVT, Assistant Professor of Vascular Surgery, Department of Surgery, Emory University School of Medicine, 101 Woodruff Circle, WMB, Suite 5105, Atlanta, GA, 30322. Telephone: 404-727-8329. Fax: 404-712-5826. Email: lbrewst@emory.edu.

Christopher T. Johnson, BS, and Luke P. Brewster, MD, PhD, RVT, declare no conflicts of interest.

Subjects:

Keywords:

  • intima-media thickness
  • cardiovascular disease
  • renin-angiotensin system
  • angiotensin-converting enzyme inhibitor
  • angiotensin II receptor blockers

Carotid Artery Intima-Media Thickness and the Renin-Angiotensin System

Tools:

Journal Title:

Hospital Practice

Volume:

Volume 41, Number 2

Publisher:

, Pages 54-61

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Carotid artery intima-media thickness (IMT) is a biomarker for cardiovascular disease that also predicts the risk of cardiovascular mortality. Angiotensin-converting enzyme (ACE) inhibition is a unique therapeutic modality because it both treats hypertension and improves arterial health and cardiovascular disease outcomes. Controversy exists regarding the role of ACE inhibitors and angiotensin receptor blockers (ARBs) in IMT regression. Our article provides an update on how ACE inhibitors and ARBs could play a role in decreasing IMT.

Copyright information:

© Hospital Practice

Export to EndNote